市場調査レポート
商品コード
1478548

細胞および遺伝子治療製造サービスの世界市場:2033年までの機会と戦略

Cell And Gene Therapy Manufacturing Services Global Market Opportunities And Strategies To 2033

出版日: | 発行: The Business Research Company | ページ情報: 英文 279 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
細胞および遺伝子治療製造サービスの世界市場:2033年までの機会と戦略
出版日: 2024年05月13日
発行: The Business Research Company
ページ情報: 英文 279 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の細胞および遺伝子治療製造サービス市場は、2018年に38億6,006万米ドルと評価され、2023年まで12.0%以上のCAGRで成長しました。

自己免疫疾患の増加

実績期間中、自己免疫疾患の発生率の増加が細胞および遺伝子治療製造サービス市場の成長を支えました。自己免疫疾患とは、免疫系が誤って身体の細胞、組織、臓器を攻撃し、炎症や機能不全を引き起こす状態を指します。自己免疫疾患の罹患率の増加は、遺伝的素因、環境要因、ライフスタイルの変化の組み合わせに起因しています。細胞および遺伝子治療製造サービスは、自己免疫疾患に対する精密治療を開発する上で極めて重要であり、有効性と安全性を向上させ、免疫系を調節する標的治療を提供します。

目次

第1章 エグゼクティブサマリー

  • 細胞および遺伝子治療製造サービス-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポートの構造

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 細胞および遺伝子治療製造サービス市場定義とセグメンテーション
  • 市場セグメンテーション:タイプ別
    • 遺伝子治療
    • 細胞療法
  • 市場セグメンテーション:適応症別
    • 中枢神経系疾患
    • 眼科疾患
    • 心血管疾患
    • 感染症
    • 整形外科疾患
    • 腫瘍疾患
    • 代謝性疾患
    • その他の病気
  • 市場セグメンテーション:用途別
    • 商業製造
    • 臨床製造
  • 市場セグメンテーション:エンドユーザー別
    • 学術研究機関
    • 製薬およびバイオテクノロジー企業
    • その他のエンドユーザー

第7章 細胞および遺伝子治療製造サービス市場:マクロ経済シナリオ

  • COVID-19の影響、細胞および遺伝子治療製造サービス市場
  • ウクライナ戦争の影響、細胞および遺伝子治療製造サービス市場
  • 高インフレの影響、細胞および遺伝子治療製造サービス市場

第8章 主要な市場動向

  • 製造能力拡大に向けた戦略的投資
  • がん治療生産プロセスの進歩に向けた戦略的連携
  • 次世代CAR-T療法の開発
  • 革新的な技術による細胞・遺伝子治療製造の強化
  • 細胞および遺伝子治療の製造における効率性を高める革新的なソリューション

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因2018-2023
    • 市場抑制要因2018-2023
  • 市場成長予測, 2023-2028, 2033F
    • 市場促進要因2023-2028
    • 市場抑制要因2023-2028

第10章 世界の細胞および遺伝子治療製造サービス市場:セグメンテーション

  • 世界の細胞および遺伝子治療製造サービス市場:タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の細胞および遺伝子治療製造サービス市場:適応症別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の細胞および遺伝子治療製造サービス市場:用途別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の細胞および遺伝子治療製造サービス市場:エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第11章 細胞および遺伝子治療製造サービス市場:地域・国別分析

  • 世界の細胞および遺伝子治療製造サービス市場:地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の細胞および遺伝子治療製造サービス市場:国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Thermo Fisher Scientific Inc.
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務実績
  • Merck KGaA
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • F. Hoffman-La Roche Ltd.
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Charles River Laboratories International Inc.
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Catalent Inc
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • QHP Capital Acquired Applied StemCell Inc.
  • Fujifilm Corporation Acquired Atara Biotherapeutics Inc.
  • Thermo Fisher Scientific Inc. Acquired PeproTech, Inc.
  • Charles River Laboratories International, Inc. Acquired Vigene Biosciences, Inc.
  • Thermo Fisher Scientific Inc. Acquired Henogen SA

第23章 将来の見通しと潜在的な分析

  • 2028年の世界市場:新たな機会を提供する国
  • 2028年の世界市場:新たな機会を提供するセグメント
  • 2028年の世界市場:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第24章 付録

目次
Product Code: o&s1147

Cell and gene therapy manufacturing services represent a pioneering sector within the biopharmaceutical industry, dedicated to the production of innovative treatments that modify the genetic material of individuals or use living cells to treat or prevent disease.

Cell therapy involves the transfer of cells with the relevant function into a patient, often aiming to restore or establish normal cell function, replacing damaged or absent cells. Gene therapy, on the other hand, involves altering the genetic material within a patient's cells to treat or prevent disease, offering potential cures for a wide range of genetic and acquired diseases.

The global cell and gene therapy manufacturing services market was valued at $3,860.06 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 12.0%.

Rising Autoimmune Diseases

During the historic period, an increasing incidence of autoimmune disease supported the growth of the cell and gene therapy manufacturing services market. Autoimmune disease refers to conditions in which the immune system mistakenly attacks the body's cells, tissues, or organs, leading to inflammation and dysfunction. The increasing incidence of autoimmune disorders is attributed to a combination of genetic predisposition, environmental factors and lifestyle changes. Cell and gene therapy manufacturing services are crucial in developing precision therapies for autoimmune diseases, providing targeted treatments to modulate the immune system with improved efficacy and safety.

For instance, in May 2023, according to the University of Oxford, a UK-based research university, about 10% of people have autoimmune diseases. Among them, 13% are women and 7% are men. This is higher than previous estimates, which were between 3% and 9%. Therefore, the increasing incidence of autoimmune disease positively impacted the growth of the cell and gene therapy manufacturing services market during the historic period.

Development Of Next-Generation CAR T Therapies

Cell and gene therapy manufacturing services companies are focusing on the development and recruitment of clinical trials for "off-the-shelf" allogeneic cell therapy to improve CAR T therapies. For instance, in October 2022, Allogene Therapeutics, a US-based clinical-stage biotechnology company, launched the CAR T Together initiative, a pioneering effort that unites prominent oncologists from esteemed research institutions nationwide. CAR T Together is working to improve CAR T therapies by creating allogeneic options. These come from donors, making them ready to use and easy to produce in large quantities.

The global cell and gene therapy manufacturing services market is highly concentrated, with a small number of large players dominating the market. The top ten competitors in the market made up 52.01% of the total market in 2022.

Cell And Gene Therapy Manufacturing Services Global Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cell and gene therapy manufacturing services market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for cell and gene therapy manufacturing services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cell and gene therapy manufacturing services market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider cell and gene therapy manufacturing services market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by indication, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the cell and gene therapy manufacturing services market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by indication, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations - This section includes recommendations for cell and gene therapy manufacturing services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Gene Therapy; Cell Therapy
  • 2) By Indication: Central Nervous System Disorders; Ophthalmology Diseases; Cardiovascular Diseases; Infectious Diseases; Orthopedic Diseases; Oncology Diseases; Metabolic Diseases; Other Diseases
  • 3) By Application: Commercial Manufacturing; Clinical Manufacturing
  • 4) By End-User: Academic and Research Institutes; Pharmaceutical and Biotechnology Companies; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific, Inc.; Merck KGaA; F. Hoffmann-La Roche Ltd; Charles River Laboratories International Inc.; Catalent Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cell and gene therapy manufacturing services indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Cell And Gene Therapy Manufacturing Services - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Cell And Gene Therapy Manufacturing Services Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Gene Therapy
    • 6.4.2 Cell Therapy
  • 6.5 Market Segmentation By Indication
    • 6.5.1 Central Nervous System Disorders
    • 6.5.2 Ophthalmology Diseases
    • 6.5.3 Cardiovascular Diseases
    • 6.5.4 Infectious Diseases
    • 6.5.5 Orthopedic Diseases
    • 6.5.6 Oncology Diseases
    • 6.5.7 Metabolic Diseases
    • 6.5.8 Other Diseases
  • 6.6 Market Segmentation By Application
    • 6.6.1 Commercial Manufacturing
    • 6.6.2 Clinical Manufacturing
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Academic And Research Institutes
    • 6.7.2 Pharmaceutical And Biotechnology Companies
    • 6.7.3 Other End-Users

7 Cell And Gene Therapy Manufacturing Services Market - Macro Economic Scenario

  • 7.1 COVID-19 Impact On The Cell And Gene Therapy Manufacturing Services Market
  • 7.2 Impact Of The War In Ukraine On The Cell And Gene Therapy Manufacturing Services Market
  • 7.3 Impact Of High Inflation On The Cell And Gene Therapy Manufacturing Services Market

8 Major Market Trends

  • 8.1 Strategic Investments To Expand Manufacturing Capacities
  • 8.2 Strategic Collaborations For Advancing Cancer Treatment Production Processes
  • 8.3 Development Of Next-Generation CAR T Therapies
  • 8.4 Enhancement In Cell And Gene Therapy Manufacturing With Innovative Technologies
  • 8.5 Innovative Solutions Driving Efficiency In Cell And Gene Therapy Manufacturing

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Cell And Gene Therapy Manufacturing Services Market Segmentation

  • 10.1 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Cell And Gene Therapy Manufacturing Services Market, Regional and Country Analysis

  • 11.1 Global Cell And Gene Therapy Manufacturing Services Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Cell And Gene Therapy Manufacturing Services Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.2 65
    • 12.1.3 65
    • 12.1.4 65
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 77
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Cell And Gene Therapy Manufacturing Services Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Cell And Gene Therapy Manufacturing Services Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Cell And Gene Therapy Manufacturing Services Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Cell And Gene Therapy Manufacturing Services Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Thermo Fisher Scientific Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 Merck KGaA
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 F. Hoffman-La Roche Ltd.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Charles River Laboratories International Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial overview
  • 19.6 Catalent Inc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 QHP Capital Acquired Applied StemCell Inc.
  • 22.2 Fujifilm Corporation Acquired Atara Biotherapeutics Inc.
  • 22.3 Thermo Fisher Scientific Inc. Acquired PeproTech, Inc.
  • 22.4 Charles River Laboratories International, Inc. Acquired Vigene Biosciences, Inc.
  • 22.5 Thermo Fisher Scientific Inc. Acquired Henogen SA

23 Future Outlook and Potential Analysis

  • 23.1 Global Cell And Gene Therapy Manufacturing Services Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Cell And Gene Therapy Manufacturing Services Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Cell And Gene Therapy Manufacturing Services Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Appendix

  • 24.1 Geographies Covered
  • 24.2 Market Data Sources
  • 24.3 Research Methodology
  • 24.4 Currencies
  • 24.5 The Business Research Company
  • 24.6 Copyright and Disclaimer